Клиническое исследование

Percutaneously Delivered Automated Continual Fluid Removal System in Patients With Advanced Diuretic-Resistant Heart Failure

NCT: NCT06689553 · TERMINATED

NCT IDNCT06689553

СтатусTERMINATED

Дата начала2025-09-28

Завершение2026-05-05

SponsorParagate Medical LTD (INDUSTRY)

First posted2024-11-14

Last updated2026-05-15

Краткое описание

The study aims to assess the feasibility, safety, tolerability and functionality of a percutaneously delivered automated continual fluid removal System in up to 8 patients with Heart Failure (HF) and diuretic resistance. Intervention: Implanted absorption chamber, connected to an external pump. Follow up: 6 months post activation.

Официальный источник

Открыть на ClinicalTrials.gov →

Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.